Andreas Rummelt, formerly chief executive of Sandoz, the generics division of Novartis, has joined the supervisory board of Leukocare AG, a privately held company in Martinsried, Germany that provides formulation services to the biopharmaceutical industry. Dr Rummelt is currently managing partner of the consulting firm InterPharmaLink in Basel, Switzerland and is a board member of several life science companies. His appointment was made on 12 July at Leukocare’s annual general meeting.
Copyright 2016 Evernow Publishing Ltd